These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25391390)

  • 41. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
    Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.
    Park BJ; Melfi F; Mussi A; Maisonneuve P; Spaggiari L; Da Silva RK; Veronesi G
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):383-9. PubMed ID: 22104677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.
    Louie AV; Haasbeek CJ; Mokhles S; Rodrigues GB; Stephans KL; Lagerwaard FJ; Palma DA; Videtic GM; Warner A; Takkenberg JJ; Reddy CA; Maat AP; Woody NM; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):82-90. PubMed ID: 26138912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma.
    Poncelet AJ; Cornet J; Coulon C; Collard P; Noirhomme P; Weynand B;
    Eur J Cardiothorac Surg; 2008 May; 33(5):799-804. PubMed ID: 18374590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
    Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
    J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic role of the PET parameter maximum standardized uptake value in non small cell lung cancer: analysis in tumour of diameter ≥ and <25 mm.
    Pelosi E; Billè A; Skanjeti A; Errico L; Arena V; Ardissone F; Borasio P; Mancini M
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):72-80. PubMed ID: 20539268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years.
    Båtevik R; Grong K; Segadal L; Stangeland L
    Lung Cancer; 2005 Feb; 47(2):173-81. PubMed ID: 15639716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study.
    Morgant MC; Pagès PB; Orsini B; Falcoz PE; Thomas PA; Barthes Fle P; Dahan M; Bernard A;
    Eur Respir J; 2015 Oct; 46(4):1131-9. PubMed ID: 26250496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas.
    Fujisawa T; Iizasa T; Saitoh Y; Sekine Y; Motohashi S; Yasukawa T; Shibuya K; Hiroshima K; Ohwada H
    J Clin Oncol; 1999 Jul; 17(7):2086-91. PubMed ID: 10561262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Chest; 2011 Apr; 139(4):855-861. PubMed ID: 20724736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical Intervention for Non-Small-Cell Lung Cancer Patients with Pleural Carcinomatosis: Results From the Japanese Lung Cancer Registry in 2004.
    Iida T; Shiba M; Yoshino I; Miyaoka E; Asamura H; Date H; Okumura M; Tada H; Nakanishi Y; Dosaka-Akita H; Kobayashi H; Takahashi K; Inoue M; Yokoi K;
    J Thorac Oncol; 2015 Jul; 10(7):1076-82. PubMed ID: 26134225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Female sex and long-term survival post curative resection for non-small-cell lung cancer.
    Warwick R; Shackcloth M; Mediratta N; Page R; McShane J; Shaw M; Poullis M
    Eur J Cardiothorac Surg; 2013 Oct; 44(4):624-30. PubMed ID: 23509234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical and paraclinical prognostic factors in non-small cell lung cancer surgery].
    Riquet M; Rivera C; Pricopi C; Badia A; Arame A; Dujon A; Foucault C; Le Pimpec-Barthes F; Fabre E
    Rev Pneumol Clin; 2015 Oct; 71(5):264-74. PubMed ID: 26315208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer.
    Imperatori A; Sahnane N; Rotolo N; Franzi F; Nardecchia E; Libera L; Romualdi C; Cattoni M; Sessa F; Dominioni L; Furlan D
    Lung Cancer; 2017 Jun; 108():83-89. PubMed ID: 28625654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre.
    Al-Alao BS; O'Callaghan DS; Gately K; Nicholson S; Coate LE; O'Connell F; McGovern E; O'Byrne KJ; Young VK
    Ir J Med Sci; 2013 Jun; 182(2):217-25. PubMed ID: 23139062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
    Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
    Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Factors in Non-Small Cell Lung Cancer Less Than 3 Centimeters: Actuarial Analysis, Accumulative Incidence and Risk Groups.
    Peñalver Cuesta JC; Jordá Aragón C; Mancheño Franch N; Cerón Navarro JA; de Aguiar Quevedo K; Arrarás Martínez M; Vera Sempere FJ; Padilla Alarcón JD
    Arch Bronconeumol; 2015 Sep; 51(9):431-9. PubMed ID: 25596989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer.
    Cho S; Yum S; Kim K; Jheon S
    Eur J Cardiothorac Surg; 2018 Sep; 54(3):554-559. PubMed ID: 29490049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.